FIRST AMENDMENT AGREEMENT This FIRST AMENDMENT AGREEMENT dated as of December 30, 1997, by and between VERSICOR INC., a Delaware corporation (the "COMPANY"), and FLEET NATIONAL BANK (the "Bank"). WHEREAS, the Loan Agreement (as defined below) provides...Loan Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Massachusetts
DECEMBER 9, 1997 BETWEEN SEPRACOR INC.Administrative Services Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
VERSICOR INC.Common Stock Purchase Warrant • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
RECITALSIndemnification Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
Exhibit 10.36 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is entered into by and between Versicor Inc., a Delaware corporation (the "Company"), and Timothy J. Henkel, M.D., Ph.D. (the "Executive"), as of the 18th day of December,...Employment Agreement • April 2nd, 2001 • Versicor Inc /Ca • Pharmaceutical preparations • California
Exhibit 10.32 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is entered into by and between Versicor Inc., a Delaware corporation (the "Company"), and Dov A. Goldstein, M.D. (the "Executive"), as of the 28th day of July 2000....Employment Agreement • July 25th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • California
RECITALSLicense Agreement • July 5th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Indiana
RECITALSInvestors' Rights Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • California
VICURON PHARMACEUTICALS INC. and as Warrant Agent FORM OF DEBT SECURITIES WARRANT AGREEMENT Dated as ofWarrant Agreement • February 13th, 2004 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
DEBT SECURITIES WARRANT AGREEMENT, dated as of between Vicuron Pharmaceuticals Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
LICENSE AGREEMENTLicense Agreement • July 5th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • England and Wales
Exhibit 10.35 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is entered into by and between Versicor Inc., a Delaware corporation (the "Company"), and Zhengyu Yuan (the "Executive"), as of the 28th day of July 2000. WHEREAS, the...Employment Agreement • July 25th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • California
RECITALSIndemnification Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
Exhibit 10.11.1 ADDENDUM NO. 1 TO COLLABORATION AGREEMENT This Addendum No. 1 to Collaboration Agreement ("Addendum"), is made as of this ____ day of January, 2001, by and between Versicor Inc., a Delaware corporation having a principal place of...Collaboration Agreement • April 2nd, 2001 • Versicor Inc /Ca • Pharmaceutical preparations
Versicor Inc.Underwriting Agreement • July 25th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • New York
VERSICOR INC.Non-Statutory Stock Option Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations
RECITALSIndemnification Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
Exhibit 10.22 INDUSTRIAL LEASE DEFINED TERMS. Effective Date: November 18, 1996. Landlord: ARCADIA-TAVISTOCK, L.C., a Virginia limited liability company, doing business as Arcadia-Tavistock LLCIndustrial Lease • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations
RECITALSIndemnification Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • Delaware
STOCK OPTION AGREEMENT Pursuant to the Grant Notice and this Stock Option Agreement, the Company has granted you an option to purchase the number of shares of the Company's common stock ("Common Stock") indicated in the Grant Notice at the exercise...Stock Option Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations
DEPOSIT AGREEMENTDeposit Agreement • February 13th, 2004 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
DEPOSIT AGREEMENT, dated as of [ ] among Vicuron Pharmaceuticals Inc., a Delaware corporation, [ ], a [ ] under the laws of the State of [ ], as Depositary, and all holders from time to time of Receipts issued hereunder.
Corporate Headquarters Versicor Inc., 111 Locke Drive, Ste 2 Marlborough, MA 01752 (508) 481-7600 Telefax (508) 481-7683 CONSULTING AGREEMENT This Consulting Agreement ("AGREEMENT"), effective as of January 1, 1997, is between VERSICOR INC....Consulting Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations
EXHIBIT 4.1 ------------------------------------------------------------------- ------------- SHAREHOLDER RIGHTS AGREEMENT by and betweenShareholder Rights Agreement • July 11th, 2001 • Versicor Inc /Ca • Pharmaceutical preparations • New York
VERSICOR INC.Incentive Stock Option Agreement • June 9th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations
6,000,000 Shares VICURON PHARMACEUTICALS INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 18th, 2003 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
VICURON PHARMACEUTICALS INC., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) 6,000,000 shares of its common stock, $0.001 par value per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional 900,000 shares of its Common Stock, $0.001 par value per share (the “Additional Shares”), if and to the extent that you, as managers of the offering, shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, $0.001 par value per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
300,000 Fremont, California December 28, 2000 AMENDED AND RESTATED SECURED PROMISSORY NOTE This Amended and Restated Secured Promissory Note shall supersede in its entirety that certain Secured Promissory Note, dated December 21, 2000, by and between...Secured Promissory Note • April 2nd, 2001 • Versicor Inc /Ca • Pharmaceutical preparations • California
4,800,000 Shares VICURON PHARMACEUTICALS INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • October 1st, 2004 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
VICURON PHARMACEUTICALS INC., a Delaware corporation (the “Company”), proposes to issue and sell to MORGAN STANLEY & CO. INCORPORATED (the “Underwriter”) 4,800,000 shares of its common stock, $0.001 par value per share (the “Firm Shares”). The Company also proposes to issue and sell to you not more than an additional 720,000 shares of its common stock, $0.001 par value per share (the “Additional Shares”), if and to the extent that you shall have determined to exercise the right to purchase such shares of common stock granted to you in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock, $0.001 par value per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
VICURON PHARMACEUTICALS INC. and [ ], as Warrant Agent FORM OF COMMON STOCK WARRANT AGREEMENT Dated as ofWarrant Agreement • February 13th, 2004 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
COMMON STOCK WARRANT AGREEMENT, dated as of [ ] between Vicuron Pharmaceuticals Inc., a Delaware corporation (the “Company”) and [ ], a [corporation] [national banking association] organized and existing under the laws of [ ] and having a corporate trust office in [ ], as warrant agent (the “Warrant Agent”).
SECOND AMENDMENT TO LEASELease • March 3rd, 2003 • Versicor Inc /Ca • Pharmaceutical preparations
THIS SECOND AMENDMENT TO LEASE (the "Second Amendment") is entered into this 17 day of December, 2002, between EXECUTIVE TERRACE INVESTORS, L.P. ("Landlord"), and VERSICOR INC., a Delaware corporation ("Tenant").
STOCK OPTION AGREEMENTStock Option Agreement • March 3rd, 2003 • Versicor Inc /Ca • Pharmaceutical preparations
Pursuant to the Grant Notice and this Stock Option Agreement, the Company has granted you an option to purchase the number of shares of the Company's common stock ("Common Stock") indicated in the Grant Notice at the exercise price indicated in the Grant Notice.
RECITALSResearch Collaboration, Contract Service and License Agreement • July 5th, 2000 • Versicor Inc /Ca • Pharmaceutical preparations • New York
PRIVATE AGREEMENT betweenPrivate Agreement • July 7th, 2003 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations
GRUPPO LEPETIT S.p.A., having its registered office at Via R. Lepetit 8, Lainate (MI), Milan, Tax and VAT No. 0079596015, and Milan Companies Registry no. 22409,—in the person of its pro tempore legal representative,
STOCK OPTION AGREEMENTStock Option Agreement • March 3rd, 2003 • Versicor Inc /Ca • Pharmaceutical preparations
Pursuant to the Grant Notice and this Stock Option Agreement, the Company has granted you an option to purchase the number of shares of the Company's common stock ("Common Stock") indicated in the Grant Notice at the exercise price indicated in the Grant Notice.
INDEMNITY AGREEMENTIndemnification Agreement • March 16th, 2005 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Indemnity Agreement (this “Agreement”) is made as of March 6, 2003 by and between Vicuron Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Dov A. Goldstein, M.D. (the “Indemnitee”), an officer of the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • October 9th, 2002 • Versicor Inc /Ca • Pharmaceutical preparations
THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into by and between Versicor Inc., a Delaware corporation (the "Company"), and Francesco Parenti (the "Executive"), as of this 30th day of July, 2002 (the "Execution Date").
VICURON PHARMACEUTICALS INC. and [ ], as Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated as ofWarrant Agreement • February 13th, 2004 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
PREFERRED STOCK WARRANT AGREEMENT, dated as of between Vicuron Pharmaceuticals Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
